Status:
NOT_YET_RECRUITING
fMRI-based Neurofeedback to Relieve Drug-resistant Auditory Hallucinations
Lead Sponsor:
University Hospital, Lille
Collaborating Sponsors:
National Research Agency, France
Conditions:
Schizophrenia
Hallucinations, Auditory
Eligibility:
All Genders
18-60 years
Phase:
NA
Brief Summary
The INTRUDE trial aims at assessing the efficacy of an fMRI-based neurofeedback procedure on drug-resistant auditory hallucinations. Hallucinations are complex and transient mental states associated w...
Eligibility Criteria
Inclusion
- Schizophrenia (according to the DSM-5 classification)
- Frequent auditory hallucinations (SAPS item #1 ≥ 4)
- Stable medication for at least 30 days
- Absence of chronic neurological disorder (including seizure)
- Able to provide free written consent to participate in the research
Exclusion
- Pregnancy
- Contraindication to MRI scan
- Claustrophobia
- No social insurance
Key Trial Info
Start Date :
December 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2026
Estimated Enrollment :
84 Patients enrolled
Trial Details
Trial ID
NCT04798131
Start Date
December 1 2022
End Date
July 1 2026
Last Update
March 25 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.